amino acid analysis
play

Amino Acid Analysis- Back to basics. Fiona Carragher Biochemical - PowerPoint PPT Presentation

Amino Acid Analysis- Back to basics. Fiona Carragher Biochemical Sciences GSTS Pathology St Thomas Hospital London Amino acid analysis Why are amino acids important When to consider amino acid analysis Available methodology


  1. Amino Acid Analysis- Back to basics…. Fiona Carragher Biochemical Sciences GSTS Pathology St Thomas’ Hospital London

  2. Amino acid analysis  Why are amino acids important  When to consider amino acid analysis  Available methodology  Limitations and pitfalls

  3. Amino Acid Structure  Amino group (-NH 2 ) O OH C  Carboxyl group (-COOH) H N C H  Distinctive R group H R

  4. Amino Acids  Essential  Non-essential Phenylalanine Tyrosine Threonine Aspartate Methionine Asparagine Lysine Alanine Tryptophan Serine Leucine Glycine Isoleucine Cysteine Valine Glutamine Histidine Glutamate Proline Arginine

  5. Amino acid disorders  Clinically and biochemically heterogeneous  Can present at any age  Characterised by  Pathological accumulation of normal metabolites  Presence of non-physiological metabolites  Combined incidence 1:6000

  6. Primary amino acid disorders  Phenylketonuria  Urea Cycle Disorders  Tyrosinaemia (I/II/III)  OTC deficiency  Maple Syrup Urine  CPS deficiency Disease  Citrullinaemia  Homocystinuria  Argininosuccinic  Non-Ketotic aciduria Hyperglycinaemia  Argininaemia  Hyperprolinaemia (I/II)  NAGS deficiency  Sulphite oxidase def  HHH  OAT deficiency

  7. Primary renal amino acid disorders  Cystinuria  Cystine, Ornithine, Arginine, Lysine  Hartnup disease  Neutral amino aciduria  Lysinuric protein intolerance  Lysine, Ornithine, Arginine  Iminoglycinuria  Proline, Hydroxyproline, Glycine

  8. Secondary causes of increased amino acids Generalised aminoaciduria Increases in plasma  Fanconi Syndrome  Alanine- lactic acidaemia  Galactosaemia  Glutamine- hyperammmonaemia  Tyrosinaemia type I  Methionine/tyrosine- liver  Cystinosis disease  Isoleu/leu/val- ketosis Increases in urine  Glycine- renal immaturity, anticonvulsant Rx

  9. Some pitfalls to avoid  Not always increased amino acids  Serine deficiency  Free amino acids  Homocystinuria  Urine homocystine not sensitive  Analysis of choice is total homocysteine

  10. When to consider amino acid analysis  Neonate- Lethargy/coma/seizures/vomiting  Hyperammonaemia  Hypoglycaemia  Ketosis  Metabolic acidosis or lactic acidaemia  Metabolic decompensation/encephalopathy  Unexplained Liver disease  Unexplained developmental delay  Renal disorders- Calculi, Tubulopathy

  11. Specific considerations  Gyrate atrophy of retina  Ornithine Amino Transferase deficiency  Marfan-like appearance/Vascular abnormalities  Homocystinuria (Cystathione B Synthase def)  Hyperkeratosis  Tyrosinaemia Type II

  12. Choice of sample  Plasma  Most informative  Often not the sample of choice by families  Urine  AA concentrations much more variable  Prone to interference from medication  Necessary for diagnosis of renal transport disorders  CSF  Useful in specific disorders  Paired with plasma

  13. Amino acid analysis  Spot test  Qualitative screening  TLC  HVE  Quantitative analysis  HPLC  AAA  TMS

  14. Spot tests  Ferric Chloride  Reacts with a number of compounds to form a colour  PKU, Tyrosinaemia, MSUD  Cyanide/Nitroprusside  Reacts with sulphur containing amino acids  Homocystinuria, Cystinuria  2,4 Dinitrophenylhydrazine  Reacts with branch-chain keto acids and phenylketones  MSUD, PKU

  15. Spot tests ADVANTAGES LIMITATIONS  Cheap  Prone to interference  Easy  Neither sensitive or specific  No expensive equipment required  May mislead investigations  Health and safety issues

  16. Qualitative analysis  Thin Layer Chromatography  1D/2D  Ninhydrin to visualise  Selective staining increases number of compounds identified  High Voltage Electrophoresis

  17. Qualitative screening ADVANTAGES LIMITATIONS  Cheap  Significant staff time  Can be used to pre-screen  Technically demanding samples before referring  Interpretation requires experience  Does not identify all compounds of interest  May only detect gross abnormalities

  18. TLC- Maple Syrup Urine Disease

  19. Quantitative analysis  Separation of free amino acids  Identification of compounds  UV detection- retention time  MS detection  Quantitation of compounds  Comparison to standards

  20. Amino acid analyser (AAA)

  21. Quantitative analysis- AAA ADVANTAGES LIMITATIONS  Long run times  Dedicated instrument  Significant maintenance  Specific for amino acids  Will identify all  Often running at capacity compounds of interest  Urgent cases need rapid results

  22. AAA- separation

  23. AAA- Maple Syrup Urine Disease alloisoleucine

  24. Quantitative analysis- TMS

  25. Quantitative analysis- TMS ADVANTAGES LIMITATIONS  Established in IEM field  Expensive capital cost  Can measure other  Expertise in technology compounds of interest on required same injection  Isobaric/isomeric  Simple sample prep compounds require separation  Rapid results  Ideal for targeted screen

  26. TMS-Maple Syrup Urine Disease

  27. TMS- Future of routine AA analysis  Rapid Commun in Mass Spec Piraud et al 19(22):3287-97  76 Amino acids detected  Ion pairing reversed phase LC linked to positive electrospray MS  Throughput of 2 samples per hour

  28. TMS-Amino acid analysis 9.5e5 9.0e5 8.5e5 Aminoacid analysis by 8.0e5 MSMS (,API4000) 7.5e5 Cit, Orn, Arg, ArgS*, 7.0e5 6.5e5 ArgSanh*, Gln, Lys*, 6.0e5 Leu, Ile,Val, Gly, Ala, I n t e n s i t y , c p s 5.5e5 Met, Phe, Tyr, Creat 5.0e5 4.5e5 4.0e5 3.5e5 3.0e5 2.5e5 2.0e5 1.5e5 1.0e5 4.21 5.0e4 3.32 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 Time, min

  29. Conclusion  Understand the limitations of strategy  State which disorders are confidently excluded  In clinical emergency  Rapid targeted TMS testing  Good communication to specialist centre

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend